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Popeye domain-containing proteins 1 and 2 (POPDC1 and POPDC2) are
transmembrane proteins involved in cyclic AMP-mediated signalling processes and are
required for normal cardiac pacemaking and conduction. In order to identify novel
protein interaction partners, POPDC1 and 2 proteins were attached to beads and
compared by proteomic analysis with control beads in the pull-down of proteins from
cultured human skeletal myotubes.
Results
There were highly-significant interactions of both POPDC1 and POPDC2 with XIRP1
(Xin actin binding repeat-containing protein 1), actin and, to a lesser degree, annexin
A5. In adult human skeletal muscle, both XIRP1 and POPDC1/2 were present at the
sarcolemma and in T-tubules. The interaction of POPDC1 with XIRP1 was confirmed in
adult rat heart extracts. Using new monoclonal antibodies specific for POPDC1 and
POPDC2, both proteins, together with XIRP1, were found mainly at intercalated discs
but also at T-tubules in adult rat and human heart.
Conclusions
Mutations in human  POPDC1  ,  POPDC2  and in human  XIRP1  , all cause
pathological cardiac arrhythmias, suggesting a possible role for POPDC1/2 and XIRP1
interaction in normal cardiac conduction.
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Dear Dr. Latto and The Editorial Staff,
Thank you for the editorial comments.
We have made the necessary corrections as follows:
1. Availability of Data and Materials:
Thank you for providing links in your ‘Availability of Data and Materials’ statement.
However, we note that the link is not found. Please update links within the manuscript:
Brackets have been removed from around the link so that it now works.
2. Gels:
We note that some of the gel/blot images are not accurately delineated. The grouping
of gels/blots cropped from different parts of the same gel, or from different gels, fields,
or exposures must be made explicit (e.g., using clear delineation either with dividing
lines or white space) and described in the figure legend.
Additionally, we note that the full images for the first line of each image (Figure 1A, B,
C and D) are missing from the Additional File. Please provide all full images for in-text
images within the Additional File, clearly labelled:
Thank you for drawing our attention to the problems with Figure 1, which have now
been corrected. The figure legend has been altered to describe accurately that
molecular weight markers are colourimetric images and antibody blots are
chemiluminescence. Where lanes are developed for different exposure times or where
lanes have been moved from non-adjacent positions, these are delineated with black
lines and described in the legend.
Additional file 2 has been altered so that it now contains the original colourimetric
images, which show the molecular weight markers that were used for the first lanes in
Figure 1. The lanes from the original blots that were used in Figure 1 are clearly
labelled in Additional File 2.
3. Rats:
In the methods section, please clarify the original source of the rat heart used in your
study. If required, please also detail the euthanization methods used in your study.
In the “Methods” section we have included the following sentence:
“The heart was removed from a five month old Sprague Dawley rat that had been
euthanized humanely with an overdose of pentobarbitone anesthetic (0.5 mL/100g) via
intraperitoneal injection.”
“Ethics approval and consent to participate” contains the following sentence:
“All animal procedures were performed with approval of the Keele University Animal
Welfare and Ethical Review Body and conducted under the licensed authority of the
UK Home Office.”
We hope that the revised manuscript is now suitable for publication in BMC Molecular
and Cell Biology.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Thank you. Best regards,
Ian Holt
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Abstract 1 
Background: Popeye domain-containing proteins 1 and 2 (POPDC1 and POPDC2) are 2 
transmembrane proteins involved in cyclic AMP-mediated signalling processes and are 3 
required for normal cardiac pacemaking and conduction. In order to identify novel protein 4 
interaction partners, POPDC1 and 2 proteins were attached to beads and compared by 5 
proteomic analysis with control beads in the pull-down of proteins from cultured human 6 
skeletal myotubes. 7 
Results: There were highly-significant interactions of both POPDC1 and POPDC2 with XIRP1 8 
(Xin actin binding repeat-containing protein 1), actin and, to a lesser degree, annexin A5. In 9 
adult human skeletal muscle, both XIRP1 and POPDC1/2 were present at the sarcolemma 10 
and in T-tubules. The interaction of POPDC1 with XIRP1 was confirmed in adult rat heart 11 
extracts.  Using new monoclonal antibodies specific for POPDC1 and POPDC2, both proteins, 12 
together with XIRP1, were found mainly at intercalated discs but also at T-tubules in adult 13 
rat and human heart. 14 
Conclusions: Mutations in human POPDC1, POPDC2 and in human XIRP1, all cause 15 
pathological cardiac arrhythmias, suggesting a possible role for POPDC1/2 and XIRP1 16 
interaction in normal cardiac conduction. 17 
 18 
Keywords 19 
Popeye domain-containing, Xin actin binding repeat-containing, Cardiac conduction, 20 
Intercalated discs, Transverse tubules. 21 
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Background 1 
Popeye domain containing protein 1 (POPDC1), also known as blood vessel epicardial 2 
substance (BVES), was first found in chicken heart by subtractive hybridisation [1,2]. Popdc1 3 
and two related gene family members, Popdc2 and Popdc3, were identified in mammals and 4 
shown to be developmentally regulated and preferentially expressed in cardiac and skeletal 5 
muscle [2]. Human POPDC1 is found on chromosome 6q21 along with POPDC3 in tandem 6 
array, whereas POPDC2 is found on human chromosome 3q13.33. The POPDC proteins are 7 
highly conserved throughout the animal kingdom, suggesting that they play an essential role 8 
[3]. 9 
POPDC proteins consist of a short extracellular N-terminal sequence which is 10 
glycosylated, three transmembrane domains, a conserved intracellular Popeye domain and 11 
a variable C-terminal domain which is isoform-specific, contains regions of low complexity 12 
and may be phosphorylated [4]. POPDC1 exists at the plasma membrane as a homodimer, 13 
which is stabilised by disulphide bonds [5,6]. The predicted secondary structure of the 14 
Popeye domain contains a cyclic nucleotide binding domain, which binds the second 15 
messenger cyclic adenosine 3’,5’-monophosphate (cAMP) with high affinity [7]. Interaction 16 
between POPDC proteins and the potassium two pore domain channel subfamily K member 17 
2 (KCNK2, also known as TREK-1) has been demonstrated, which leads to an increase in 18 
KCNK2 current in isolated mouse sinus node myocytes, and this activity was reduced by an 19 
increase in cAMP levels [7]. A number of other membrane proteins have been reported to 20 
interact with POPDC proteins, including caveolin-3 (CAV3) in mouse cardiomyocytes, which 21 
is a major component of caveolae in striated muscle membranes [8]. 22 
A homozygous missense variant in POPDC1 has been found in a family with cardiac 23 
arrhythmia and limb-girdle muscular dystrophy (LGMD). This autosomal recessive mutation 24 
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in POPDC1 is associated with reduced cAMP affinity [9]. More recently, three homozygous 1 
loss-of-function mutations in POPDC1 were identified in three families with LGMD and 2 
cardiac conduction abnormalities [10] and a missense mutation in POPDC1 was observed in 3 
a patient with contractures and possible mild cardiac involvement [11]. A heterozygous 4 
nucleotide substitution in POPDC2 has been associated with severe atrioventricular block 5 
[12]and homozygous missense variants in POPDC3 have been associated with limb girdle 6 
muscular dystrophy in the absence of a cardiac phenotype [13]. POPDC1 protein was down-7 
regulated with abnormal immunolocalisation in failing human hearts and POPDC1 and 8 
POPDC3 mRNA levels were reduced in the left ventricles of end-stage failing hearts [14]. 9 
Popdc1 null mice showed impaired skeletal muscle regeneration [15] and increased 10 
sensitivity towards ischemia reperfusion [8]. Moreover, mice with null-mutations in Popdc1 11 
or Popdc2 developed a stress-induced sinus node bradycardia due to pacemaker 12 
dysfunction [7,16]. Knockdown of popdc2 in zebrafish by injecting embryos with morpholino 13 
oligonucleotides resulted in the aberrant development of skeletal muscle and heart. A 14 
reduction in oligonucleotide concentration lead to an improvement in the skeletal muscle 15 
pathology, but abnormalities in the cardiac conduction system remained, resulting in 16 
cardiac arrhythmia and a reduction in heart rate [17]. 17 
Immunolocalization studies with polyclonal antibodies have shown that POPDC1 and 18 
POPDC2 generally localise to the sarcolemma of control skeletal muscle, but this membrane 19 
localisation was greatly reduced in muscle tissue from patients with pathogenic mutations in 20 
POPDC1 [9,10]. In the heart, POPDC1 and POPDC2 were found at the plasma membrane of 21 
cardiomyocytes, with high levels in the cardiac conduction system [7,18]. 22 
 In addition to the essential roles that POPDC proteins play in the maintenance of 23 
structure and function of skeletal muscles and in cardiac pacemaking and conduction, 24 
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POPDC1 may play a role in tumor formation [19]. POPDC1 is thought to have a tumor 1 
suppressor function and decreased POPDC1 expression due to DNA methylation occurs in 2 
the early stages of a number of cancers [reviewed: 20,21]. 3 
Here we report a proteomic study to identify novel POPDC1/2-interacting proteins. 4 
The most significant hit with both POPDC1 and POPDC2 was XIRP1 (Xin actin binding repeat 5 
containing 1, also known as Xin or cardiomyopathy-associated protein 1 (CMYA1)). Pull-6 
down and co-immunoprecipitation experiments confirmed the interaction of XIRP1 with 7 
POPDC1 and POPDC2. POPDC1/2 and XIRP1 displayed colocalization at the intercalated disk 8 
and in T-tubules. Mutations for both genes in model organisms [7,17,22,23] and patients  9 
[9,10,24] have been associated with severe cardiac conduction defects and impaired 10 
skeletal muscle regeneration was reported for both Popdc1 [15] and Xirp1 [25,26] null 11 
mutants. This suggests some overlapping function between POPDC1 and XIRP1, which could 12 
be based in part on the interaction reported here. 13 
 14 
 15 
Results 16 
 17 
XIRP1 and cardiac actin are the highest-scoring binding partners for both POPDC1 and 18 
POPDC2 in skeletal muscle myotubes  19 
With the goal of identifying novel protein interaction partners for POPDC proteins in 20 
skeletal muscle, POPDC proteins available as GST-fusion “bait” proteins (mouse POPDC1 or 21 
POPDC2) were attached to glutathione beads and used to pull-down proteins from RIPA 22 
extracts of human skeletal myotubes. Proteins pulled down by the beads were identified by 23 
mass spectrometry (unfiltered results shown in: Additional file 1). Cardiac actin and XIRP1 24 
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had the highest scores for a number of significant peptides identified by mass spectrometry 1 
(Table 1) for both mouse POPDC1 and mouse POPDC2, after eliminating non-specific binding 2 
of proteins to control beads (no fusion protein attached). Annexin A5 was also present in 3 
both pull-downs. For further study, we selected from Table 1 those proteins with known 4 
involvement in cardiac conduction and / or cardiomyopathy: XIRP1 and annexin A5. 5 
Cardiac actin is the principal actin isoform during early stages of skeletal myogenesis 6 
and is only gradually replaced by skeletal muscle actin in adult skeletal muscle [27], so it is 7 
not surprising that the cardiac isoform was detected in myotube extracts.  8 
 9 
TABLE 1 TO BE INSERTED HERE 10 
 11 
Confirmation by western blotting of POPDC1 interaction with XIRP1 in extracts of both 12 
human myotube cultures and adult rat heart 13 
The presence of XIRP1 in POPDC1/2 pull downs was confirmed by western blotting 14 
with a commercial anti- XIRP1 antibody (Fig. 1A upper blot). Figure 1A lower blot is a loading 15 
control showing antibody against the GST “bait” protein.  XIRP1 was also 16 
immunoprecipitated from the same human myotube extracts by mAb 1C12 against POPDC1 17 
(Fig. 1B). Western blots are representative of pull-downs repeated using three separate 18 
extracts of the cultured myotube cell line. Recombinant POPDC1 attached to glutathione 19 
beads also pulled-down XIRP1 from a RIPA extract of adult rat heart ventricle (Fig. 1D). The 20 
pull down of annexin A5 by recombinant POPDC1 from myotubes was also confirmed by 21 
western blotting (Fig. 1C). (Uncropped blots shown in: Additional file 2) 22 
 23 
New monoclonal antibodies against POPDC1 and POPDC2 24 
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Monoclonal antibodies were prepared against recombinant protein preparations and 1 
selected for their recognition of human POPDC1 or POPDC2 proteins using techniques 2 
described previously [28]. Immunofluorescence specificity of the new POPDC1 1C12 (Fig. 2A) 3 
and POPDC2 12G12 (Fig. 2B) mAbs was shown by the staining of COS7 cells transfected with 4 
recombinant POPDC1 or POPDC2 respectively. POPDC1 1C12 did not recognise transfected 5 
POPDC2 and mAb POPDC2 12G12 did not recognise transfected POPDC1. Specificity of the 6 
mAbs was further demonstrated by competition experiments. Pre-incubation of mAb 7 
POPDC1 1C12 with recombinant POPDC1, but not with recombinant POPDC2, inhibited 8 
localisation of the mAb to the sarcolemma of human skeletal muscle (Fig. 2C). Similarly, pre-9 
incubation of mAb POPDC2 12G12 with recombinant POPDC2, but not with recombinant 10 
POPDC1, inhibited sarcolemmal localisation (Fig. 2D). 11 
  12 
XIRP1 and POPDC1/2 are found, together with annexin A5, at intercalated discs and 13 
transverse tubules in rat or human heart sections 14 
In rat heart, XIRP1 and POPDC2 were both present at intercalated discs and near the 15 
Z-line of myofibrils (Fig. 3A,B). Unlike XIRP1, however, POPDC2 was also present at the 16 
cardiac sarcolemma (Fig. 3B). A similar staining pattern in heart was reported by Alcalay et 17 
al. [8] for POPDC1 and Soni et al. [29] for POPDC2. Intercalated discs were identified using a 18 
connexin 43 antibody, which stains neither sarcolemma nor the Z-line (Fig. 3A). Our human-19 
specific POPDC1 mAb does not recognize the rat protein, but a commercial POPDC1 20 
antibody (BVES pAb STJ22848) gave similar results on rat heart to our POPDC2 mAb (Fig. 21 
3C). Fig 3C also shows the location of POPDC1 near the Z-line which lies at the centre of the 22 
actin I-band stained by phalloidin (ALEXA 488 - phalloidin). This staining appears to 23 
correspond to transverse tubules, since an antibody against amphiphysin II, a marker for T-24 
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tubules, gave a similar staining pattern as POPDC2 (Fig. 3E) and POPDC proteins have 1 
transmembrane domains. Annexin A5 (ANXA5) was also present in both POPDC1 and 2 
POPDC2 pull downs (Table 1) and antibodies against this protein also located it close to the 3 
Z-line (Fig. 3D). Annexin A5 is a known component of the sarcolemma, transverse tubules 4 
and intercalated discs in the heart [30]. 5 
In human heart, mAbs POPDC1 1C12 (Fig. 4A) and POPDC2 12G12 (Fig. 4B) stained 6 
the intercalated discs and the cardiac sarcolemma whereas XIRP1 was present at the 7 
intercalated discs only. There were similar staining patterns in rat and human hearts, but 8 
cross striations were difficult to resolve in the human heart sections. In low power 9 
microscopy (40x) of human heart, T-tubules were only faintly-stained (Fig. 4) compared with 10 
the higher power microscopy (63x) of rat heart (Fig.3), suggesting that intercalated discs 11 
may be the major site of POPDC-XIRP1 interaction in the heart. Figures 3 and 4 show 12 
representative images of results that were obtained with sections from two different rat 13 
hearts and confirmed with the sections from a human heart. 14 
 15 
POPDC1, POPDC2, XIRP1 and annexin A5 are also found in T-tubules in longitudinal 16 
sections of human skeletal muscle. 17 
Figure 5A-D shows the co-localization of POPDC1 and 2, XIRP1 and annexin A5 at Z-18 
lines/T-tubules in longitudinal sections of human skeletal muscle, using a monoclonal 19 
antibody against alpha-actinin to locate Z-lines (Fig. 5C). 20 
 21 
POPDC1, POPDC2 and XIRP1 are present at the sarcolemma in transverse sections of 22 
human skeletal muscle 23 
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POPDC1 (Fig. 6A) and POPDC2 (Fig. 6B) are present at the sarcolemma in transverse 1 
sections of skeletal muscle. XIRP1 is also present at the sarcolemma, but does not co-2 
localise exactly with POPDC proteins. Figures 5 and 6 show representative images of 3 
sections from five different human muscle biopsies which gave similar results in these 4 
experiments. 5 
 6 
 7 
Discussion 8 
 Our initial proteomic study of pull-downs from human myotube extracts using 9 
recombinant POPDC1 or POPDC2 as the bait proteins showed that XIRP1 and cardiac actin 10 
were the highest-scoring hits (Table 1). XIRP1 has been located to myotendinous junctions 11 
in skeletal muscle [22] and to intercalated discs in heart [31,32]. We examined the 12 
interacting POPDC and XIRP1 proteins further by co-localization studies, bearing in mind 13 
that POPDC proteins (via zonula occludens-1, ZO-1 [33]) and XIRP1 [34] are known actin-14 
binding proteins. Proteomic studies only give clues to potential interaction partners in a 15 
single tissue; Table 1 should not be expected to include all interaction partners of POPDC 16 
proteins and all potential partners revealed by proteomics require biochemical 17 
confirmation. 18 
XIRP1 is a scaffolding protein which stabilizes and maintains the integrity of the 19 
intercalated disc. Overexpression of XIRP1 leads to increased phosphorylation of gap 20 
junction protein alpha 1 (GJA1), also known as connexin-43 (Cx43), and down-regulation of 21 
the activity of gap junctions in cardiomyocytes [35]). Knockout Xirp1 (or Xin mice develop 22 
a late-onset cardiomyopathy with conduction defects [22]. Missense mutations in XIRP1 23 
cause cardiac arrhythmias [24] and a number of mutations in XIRP1 that are classed as 24 
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deleterious have been found in patients with conditions including myalgia, proximal 1 
weakness, arrhythmia, contractures and cardiac conduction defects [11]. XIRP proteins have 2 
binding domains for both -catenin and p120-catenin, through which they attach to N-3 
cadherin in the intercalated disc [36]. Intercalated discs provide electromechanical coupling 4 
between adjacent cardiomyocytes. Depolarising current is transmitted via gap junctions in 5 
the intercalated discs from cell to cell across the heart. Defects in intercalated disc structure 6 
and function are common features of cardiomyopathy, arrhythmia and heart failure 7 
(Reviewed: [32]). 8 
Annexin A5 was also a significant interaction partner for POPDC1/2 (Table 1). 9 
Annexin A5 is upregulated in failing human hearts [37] and has been linked to plasma 10 
membrane repair in skeletal muscle [38]), a property shared with caveolin-3 [39] and XIRP1 11 
[40,41]. There is some evidence of a role for POPDC1 in the maintenance of plasma 12 
membrane integrity, as discontinuities in the plasma membrane have been observed in the 13 
grandfather of a family carrying a pathogenic homozygous missense mutation (c.602C>T, 14 
p.S201F) in POPDC1 [9]. This mutation gives rise to cardiac arrhythmia and LGMD [9].  15 
 Using new monoclonal antibodies (mAbs) specific for either POPDC1 (1C12) or 16 
POPDC2 (12G12), together with a commercial polyclonal antibody against POPDC1 (BVES), 17 
we have shown that both proteins are localized at the sarcolemma and transverse tubules in 18 
both human skeletal muscle and rat heart muscle. Partial co-localization of both XIRP1 and 19 
annexin A5 with POPDC1/2 was found in T-tubules in both cardiac and skeletal muscles. T-20 
tubules are invaginations in the plasma membrane of muscle cells, they are rich in ion 21 
channels and relay excitation signals from the external membrane to the interior of cells and 22 
are very sensitive to eccentric stretch (reviewed in [42]). In heart, POPDC1 and 2 are mainly 23 
concentrated at intercalated discs. The presence of POPDC2 at intercalated discs was also 24 
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shown by Soni et al. 2016 [29], while co-localization of XIRP1 with Connexin-43 at the 1 
intercalated discs of human hearts was shown by Xie et al. 2017 [35]. There is considerable 2 
functional overlap between POPDC proteins and XIRP proteins. In null mutants in the mouse 3 
for both gene families, a cardiac arrhythmia phenotype was reported. In the case of Popdc1 4 
and Popdc2 null mutants, a stress-induced bradycardia phenotype was observed, while at 5 
baseline the mutants showed a normal rhythmic beating heart [7]. In contrast, the Xirp1 null 6 
mutant phenotype was characterized by a late-onset cardiomyopathy with conduction 7 
defects [22]. In patients, POPDC1 has also been linked to prolonged QT interval, increased 8 
QRS duration and AV-block [43]. Interestingly, in contrast to the mouse, in zebrafish, an AV-9 
block was seen for both popdc1 and popdc2 null mutants [9,17,43]. Functional overlap is 10 
also seen in Popdc1 null mutants and Xirp1 null mutants with regard to skeletal muscle 11 
regeneration [25,26]. 12 
Although the pull-downs clearly show association between POPDC1/2, XIRP1 and 13 
actin, it is not clear whether the interactions between them are direct or indirect. It is 14 
possible that they are members of a larger complex, some components of which were not 15 
detected by proteomics for technical reasons. Earlier studies identified different binding 16 
partners for POPDC proteins, including dystrophin, dysferlin, VAMP2, VAMP3, GEFT, NDRG4, 17 
ZO-1, TREK-1; c-MYC and PR61-alpha, as well as caveolin-3 [7,8,9,33,44, ,45,46,47]. None of 18 
these are among the 340 proteins that appeared in our pull-downs, although this may be 19 
either because their interaction with POPDC is tissue-specific and not occurring in myotube 20 
cultures, or because they are present at very low levels in RIPA buffer extracts, or because 21 
they showed some non-specific binding to our control beads or because the interaction 22 
does not withstand the extraction conditions used. With numerous other interaction 23 
partners having been linked to POPDC1 and POPDC2 [4], it is not surprising that the loss-of-24 
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function phenotype of POPDC1 and XIRP1 would show only partial overlap. In this context it 1 
will also be interesting to define all components of the protein complex of which XIRP1 and 2 
POPDC1 are part in cardiac and skeletal muscle. 3 
 4 
Conclusions 5 
POPDC1/2 proteins interact with XIRP1 in skeletal myotubes and adult heart. Determining 6 
the functions of POPDC and XIRP1 proteins at the t-tubules and intercalated discs will help 7 
to understand their roles in normal cardiac and skeletal muscle function and what can go 8 
wrong when pathogenic mutations occur. 9 
 10 
Methods  11 
 12 
Popdc “bait” proteins 13 
GST fusion proteins were generated by PCR from cDNA for mouse Popdc1 (Bves, 14 
GenBank Accession No: NM_024285.3) (aa 114 to 357) and for mouse Popdc2 (GenBank 15 
Accession No: NM_001081984.2) (aa 98 to 339) and cloned into pGEX bacterial expression 16 
vectors. pGEX constructs were transformed into E. coli BL21(DE3) and induced by IPTG to 17 
give GST-fusion proteins. After incubation the cells were washed with TNE buffer and 18 
sonicated sequentially with TNE, 2M urea, 4M urea, 6M urea and 8M urea. A Coomassie 19 
Blue-stained gel showed that most of the recombinant proteins were extracted in the 6M 20 
urea fraction and these were used in subsequent work. Resultant proteins contained GST-21 
tags followed by the intracellular C-terminal tails of mPopdc1 and mPopdc2, with molecular 22 
weights of 58.3 and 57.1 kDa respectively. 23 
 24 
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Muscle cell culture and extraction 1 
A clonal immortalized human myoblast cell line from a 25-year-old control donor 2 
without neuromuscular disease was immortalized by transduction with human telomerase 3 
reverse transcriptase (hTERT) and cyclin-dependent kinase-4 (Cdk4) containing retroviral 4 
vectors, at the Institut de Myologie, Paris, as described previously [48]. Myoblasts were 5 
cultured in skeletal muscle cell growth medium (Cat No: C-23060; PromoCell GmbH, 6 
Heidelberg, Germany) containing supplement mix (Cat No: C-39365; PromoCell) with 20% 7 
Fetal Bovine Serum (Cat No: 10270; Gibco; ThermoFisher Scientific, Paisley, UK). At around 8 
80% confluency, adherent myoblasts were washed in medium lacking serum and 9 
differentiation was induced by culturing in DMEM (Cat No: 31966-021; Gibco; ThermoFisher 10 
Scientific) supplemented with Insulin (1721nM), Transferrin (68.7nM), Selenium (38.7nM) 11 
(ITS-X; Cat No: 51500-056; Gibco; ThermoFisher Scientific) and Penicillin-Streptomycin (Cat 12 
No: DE17-603E; Lonza; Verviers, Belgium). Cell culture was continued for a further 4 days, 13 
after which, over 80% of the cells had fused into myotubes. Cells cultured for pull-down 14 
experiments were extracted in RIPA buffer (1% NP-40; 0.25% sodium deoxycholate; 1mM 15 
EDTA; 150mM NaCl; 50mM Tris-HCl, pH7.4), in the presence of protease inhibitor cocktail 16 
(Sigma P8340; plus 1mM PMSF), by sonication followed by centrifugation. 17 
 18 
Pull-down and proteomic analysis 19 
Glutathione high capacity magnetic agarose beads (Cat No: G0924; Sigma) were 20 
loaded with GST-tagged “Bait” proteins (mouse Popdc1 or mouse Popdc2 or No Bait control) 21 
and then incubated with “Prey” (cultured human myotube extract in RIPA buffer). Captured 22 
proteins were digested by overnight incubation with 1% v/v trypsin at 37°C and analysed by 23 
nanoLC MSMS as described previously [49]. The MS/MS data file was analysed using the 24 
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Mascot search algorithm (Matrix Science), against the SwissProt database (May 2018) 1 
restricting the search to Homo sapiens (557,491 sequences), with trypsin as the cleavage 2 
enzyme and methionine oxidation as a variable modification. The peptide mass tolerance 3 
was set to 20 ppm and the MSMS mass tolerance to ± 0.1 Da. This analysis was used to 4 
identify medium-to-high abundance proteins that interact with Popdc proteins. 5 
 6 
Extraction and pull-down with rat heart 7 
The heart was removed from a five month old Sprague Dawley rat that had been 8 
euthanized humanely with an overdose of pentobarbitone anesthetic (0.5 mL/100g) via 9 
intraperitoneal injection. The heart was cut in half, washed with PBS, weighed, snap frozen 10 
in liquid nitrogen, transferred to a mortar and ground to a fine powder with a pestle. The 11 
liquid nitrogen was then allowed to evaporate and the powdered heart extracted with RIPA 12 
buffer with inhibitors (around 1mL buffer per 100 μg heart), sonicated on ice and 13 
centrifuged. The heart extract was used instead of myotube extract as “prey”, with mouse 14 
GST- mouse Popdc1 on glutathione beads as “bait”, as described earlier. 15 
 16 
Hybridoma production 17 
Human BVES (POPDC1) cDNA (GenBank Accession No: NM_007073.4) was a gift from 18 
D. Bader [33]. A GST fusion protein was generated by PCR from the C-terminal tail of (aa 19 
115-347) and cloning into the pGEX bacterial expression vector. This protein contains the 20 
GST tag followed by the intracellular C-terminal tail of POPDC1.  The GST-mouse Popdc2 21 
(amino acids 98 to 339) fusion protein preparation described earlier for pull-down 22 
experiments was also used for hybridoma production. Induction and extraction of the GST-23 
fusion proteins was performed as described earlier. Fusion protein in the 6M urea fraction 24 
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was used in the protocol for immunization of BALB/c mice for production of mAbs [28]. 1 
ELISA plates were coated with either the GST-POPDC fusion proteins used for immunization 2 
or with an unrelated GST-fusion protein, in order to eliminate those mAbs reacting with the 3 
GST fusion tag. Hybridoma supernatants were additionally screened for colocalisation with 4 
transfected human POPDC proteins as follows: COS-7 cells were transfected (Lipofectamine) 5 
with either hPOPDC1-YFP or hPOPDC2-FLAG tag on glass coverslips and the cells fixed and 6 
permeabilized with 50% acetone : 50% methanol. Transfected cells were incubated with 7 
hybridoma supernatants. hPOPDC1-YFP transfectants were then incubated with 5µg/ml 8 
goat anti-mouse ALEXA 546 (Cat No: A11030, Molecular Probes, Eugene, Oregon, USA). 9 
hPOPDC2-FLAG transfectants were incubated with rabbit oligoclonal anti-FLAG (Cat No: 10 
740001, Thermo Fisher Scientific), followed by 5µg/ml goat anti-mouse ALEXA 546 (Cat No: 11 
A11030, Molecular Probes) and 5µg/ml goat anti-rabbit ALEXA 488 (Cat No: A11034, 12 
Molecular Probes). DAPI was added for the final 10 minutes of incubation to counterstain 13 
nuclei and confocal microscopy performed as described below. Monoclonal antibodies 14 
POPDC1-1C12 and POPDC2-12G12 were selected because they recognized the 15 
corresponding transfected POPDC1 or POPDC2 by immunofluorescence microscopy (Fig.2). 16 
 17 
SDS-polyacrylamide gel electrophoresis and Western blotting 18 
Samples were mixed with SDS buffer (125mM Tris pH 6.8; 2% SDS; 5% 2-beta 19 
mercaptoethanol; 5% glycerol; with bromophenol blue), boiled and subjected to SDS-PAGE 20 
using 10% polyacrylamide gels and transferred to nitrocellulose membranes (Protan BA85, 21 
Whatman). Non-specific sites were blocked with 5% skimmed milk protein, membranes 22 
washed with PBS and then incubated with primary monoclonal antibodies against: XIRP1, 23 
(Xin-alpha (D-8); sc-166658; 1/100; Santa Cruz Biotechnology, Insight Biotechnology Ltd., 24 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
16 
 
Wembly, UK); or GST, mAb 17A10 (1/100). This was followed by washing in PBS and 1 
incubation with secondary antibody (peroxidase-labelled rabbit anti-mouse 2 
immunoglobulins, P0260; 1/1000; Dako, Denmark). Alternatively, for the detection of 3 
annexin A5, pAb ANXA5 (Abcam; ab14196; 1.4 g/mL) primary antibody followed by goat 4 
anti-rabbit Ig HRP (P0448; Dako; 1/1000) secondary antibody. All antibodies were diluted in 5 
PBS containing 0.05% Triton X, 0.1% BSA, 1% horse serum and 1% fetal bovine serum. XIRP1 6 
and annexin A5 antibody reacting bands were detected with SuperSignal West Femto 7 
chemiluminescent reagent (Cat No: 34094; ThermoFisher Scientific) and GST antibody 8 
reacting bands were detected with SuperSignal West Pico Plus chemiluminescent reagent 9 
(Cat No: 34580; ThermoFisher Scientific) and visualized with a ChemiDoc Touch imaging 10 
system (BioRad Ltd.). 11 
 12 
Immunoprecipitation 13 
Superparamagnetic polystyrene beads coated with monoclonal human anti-mouse 14 
IgG antibodies (Dynabeads Pan Mouse IgG; Cat No: 11041; Invitrogen) were washed with 4% 15 
bovine serum albumin in PBS and then incubated with mAb against POPDC1 (1C12) or PBS 16 
alone (control) with gentle rolling for 1 hour. Beads were then washed with PBS and 17 
incubated with cultured human myotube extract in RIPA buffer for 1 hour with rolling. 18 
Beads were thoroughly washed with RIPA buffer and then with PBS and the bound material 19 
extracted by incubating the beads with SDS sample buffer, heating to 90°C for 3 minutes 20 
and then saving the eluate. 21 
 22 
Immunofluorescence microscopy 23 
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Immunohistochemistry was performed on unfixed cryostat sections of human 1 
skeletal muscle or rat cardiac ventricle muscle. Monoclonal antibodies against: POPDC1 2 
(1C12; 1:2 dilution); POPDC2 (12G12 1:2 dilution); XIRP1 (Xin-alpha (D-8); sc-166658; 1/100); 3 
Actinin (MANDYS 141, 4A12, 1/50 [50]); were diluted and incubated on specimens for 1 4 
hour. Specimens were then washed and incubated with rabbit polyclonal antibodies: 5 
Connexin 43 (GJA1, ab11370; Abcam; 1/1000); XIRP1 (Cat No: HPA016750; Sigma; 1/150); 6 
Annexin A5 (ANXA5, ab14196; Abcam; 1/50); POPDC1/BVES (Cat No: STJ22848; St. John’s 7 
Laboratory Ltd., London, E16 2RD; 1/100); Amphiphysin (ab244375; Abcam; 1/50). Following 8 
antibody incubation, specimens were washed with PBS and then incubated with 5µg/ml of 9 
each secondary antibody which was either: goat anti-mouse ALEXA 488 (Cat No: A11029, 10 
Molecular Probes, Eugene, Oregon, USA) and goat anti-rabbit ALEXA 546 (Cat No: A11010), 11 
or with goat anti-mouse ALEXA 546 (Cat No: A11030) and goat anti-rabbit ALEXA 488 (Cat 12 
No: A11034). Secondary antibodies were diluted in PBS containing 1% horse serum, 1% fetal 13 
bovine serum and 0.1% BSA, and incubated on the sections for 1 hour. Alternatively, for 14 
some immunofluorescent labelling of rat cardiac sections, a single primary (polyclonal) 15 
antibody then single goat anti-rabbit ALEXA 546 antibody were used, followed by ALEXA-488 16 
Phalloidin (Cat No: A12383; Molecular Probes) to label filamentous actin. Finally, DAPI (at 17 
200 ng/ml) was added for the final 10 minutes of incubation to counterstain nuclei before 18 
washing and mounting the sections (Hydromount; Merck). For protein competition 19 
experiments, monoclonal antibodies were pre-incubated with 1mg/mL recombinant protein 20 
preparation for 1 h at room temperature. Images were acquired by sequential scanning with 21 
a Leica TCS SP5 spectral confocal microscope (63x/1.4 oil) (Leica Microsystems, Milton 22 
Keynes, UK), except the human heart images which were acquired with a Zeiss LSM780 23 
confocal microscope (40x/1.3 oil) (Carl Zeiss Microscopy, Cambridge, UK. 24 
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 1 
Abbreviations 2 
 3 
ACTC1  - Actin Alpha Cardiac Muscle 1 4 
ANXA5  - Annexin A5 5 
AV  - Atrioventricular 6 
BIN1  - Bridging Integrator 1 (also known as Amphiphysin II) 7 
BSA  - Bovine serum albumin 8 
BVES  - Blood Vessel Epicardial Substance (also known as POPDC1) 9 
cAMP  - Cyclic adenosine 3’,5’-monophosphate 10 
CAV3  - Caveolin 3 11 
Cdk4  - Cyclin-dependent kinase-4 12 
CMYA1 - Cardiomyopathy-associated protein 1 (also known as XIRP1) 13 
c-Myc  - MYC Proto-Oncogene 14 
COS-7  - African green monkey kidney fibroblast-like cell line 15 
Cx43  - Connexin-43 (Gap Junction Protein Alpha 1, GJA1) 16 
DAPI  - 4’,6-diamidino-2-phenylindole 17 
FLAG  - DYKDDDDK-tag 18 
FRET  - Fluorescence resonance energy transfer 19 
GEFT  - ARHGEF25 or Rho Guanine Nucleotide Exchange Factor 25 20 
GST  - Glutathione S-transferase 21 
HEK293 - Human embryonic kidney 293 cells 22 
HRP  - Horseradish peroxidase 23 
hTERT  - Human telomerase reverse transcriptase 24 
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IPTG  - Isopropyl beta-D-1-thiogalactopyranoside 1 
KCNK2  - Potassium Two Pore Domain Channel Subfamily K Member 2 (TREK-1) 2 
LGMD  - Limb-girdle muscular dystrophy 3 
mAb  - Monoclonal antibody 4 
Nano LC MSMS - Nanoscale liquid chromatography tandem mass spectrometry 5 
NDRG4 - NDRG Family Member 4 (or N-Myc Downstream-Regulated Gene 4 Protein) 6 
pAb  - Polyclonal antibody 7 
PBS  - Phosphate-buffered saline 8 
PCR  - Polymerase chain reaction 9 
PMSF  - Phenylmethylsulfonyl fluoride (serine protease inhibitor) 10 
POPDC1 - Popeye Domain Containing 1 (also known as BVES) 11 
POPDC2 - Popeye Domain Containing 2 12 
POPDC3 - Popeye Domain Containing 3 13 
PR61-alpha - Protein Phosphatase 2 Regulatory Subunit B’Alpha (PPP2R5A) 14 
RIPA buffer - Radioimmunoprecipitation assay buffer 15 
SDS - Sodium dodecyl sulfate 16 
TNE buffer - Tris-HCl, NaCl, EDTA buffer 17 
TREK-1  - Potassium Two Pore Domain Channel Subfamily K Member 2 (KCNK2) 18 
VAMP2 - Vesicle Associated Membrane Protein 2 19 
VAMP3 - Vesicle Associated Membrane Protein 3 20 
XIRP1 - Xin Actin Binding Repeat Containing 1 (also known as XIN or CMYA1 - 21 
cardiomyopathy-associated protein 1) 22 
YFP - Yellow fluorescent protein 23 
ZO-1  - Zonula Occludens Protein 1 (Tight Junction Protein 1) 24 
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 19 
Figure legends 20 
 21 
Figure 1 22 
POPDC proteins pull down and co-immunoprecipitate XIRP1 and pull down annexin A5 from 23 
human myotube extract and pull-down XIRP1 from rat heart extract. 24 
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Vertical black lines separate parts of blots that were originally non-adjacent or with different 1 
exposure times, as described. In all cases, the molecular weight markers in lane 1 were 2 
detected by colourimetric imaging and the antibody blots by chemiluminescence. (A) 3 
Glutathione beads were loaded with recombinant preparations of POPDC1, POPDC2 or not 4 
loaded (control for non-specific binding) and incubated with human myotube extracts. 5 
“Input” shows human myotube extracts diluted to 20%. Upper part of blot (A) (above 6 
72kDa) developed with mAb against XIRP1 (sc-166658) shows XIRP1 in the input and pulled 7 
down by POPDC1 and POPDC2, but not in the control. The “Input” lane had a shorter 8 
exposure time than the others and the “Control” lane was originally non-adjacent. The 9 
Lower part of blot (A) (72kDa and below) was from a separate but identical gel to the upper 10 
blot and was developed with mAb against GST tag (17A10) as a loading control. The 11 
“Control” lane was originally non-adjacent to the others. The predicted molecular weights of 12 
the Popdc1 and Popdc2 fusion proteins are 58 and 57 kDa respectively, which are indicated 13 
approximately with a single arrow. (B) Pan mouse IgG Dynabeads were loaded with 14 
monoclonal antibody against POPDC1 (1C12) or not loaded (control) and incubated with 15 
human myotube extracts. The blot was developed with XIRP1 mAb and shows XIRP1 in the 16 
input and immunoprecipitated by the POPDC1 mAb but not by unloaded control beads. 17 
*=mouse Ig H and L chains. Predicted molecular weights of human XIRP1, isoforms 1,2 and 3 18 
are 199, 122 and 56 kDa respectively. Arrows indicate bands corresponding to XIRP1 19 
isoforms 1 and 3. The “POPDC1 1C12” lane had a longer exposure compared to the other 20 
lanes and the “molecular weight markers” were not originally in lane 1. (C) Glutathione 21 
beads loaded with recombinant POPDC1 or beads alone (control) were incubated with 22 
human myotube extract. The blot was developed with pAb against annexin A5. The arrow 23 
indicates a band corresponding to annexin A5 monomer (36 kDa) in the input and POPDC1 24 
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pull-down, but absent from the non-specific binding control. The “Control” lane was 1 
originally non-adjacent to the others. (D) Glutathione beads loaded with recombinant 2 
POPDC1 or beads alone (control) were incubated with rat heart ventricle extract. The blot 3 
was developed with mAb against XIRP1. Arrows indicate bands corresponding to XIRP1 in 4 
the input and POPDC1 pull-down, but absent from the non-specific binding control. The 5 
original colourimetric and chemiluminescence images are shown in Additional File 2. 6 
 7 
Figure 2 8 
Immunofluorescent specificity of POPDC mAbs. 9 
COS-7 cells were transfected with either (A) human POPDC1 (GFP tag) or (B) human POPDC2 10 
(FLAG tag) and processed as described in “methods”. (A) mAb POPDC1 1C12 colocalised 11 
with transfected POPDC1 and (B) mAb POPDC2 12G12 colocalised with transfected POPDC2. 12 
The POPDC1 mAb did not recognise transfected POPDC2 and the POPDC2 mAb did not 13 
recognise transfected POPDC1 (not shown). (C) mAb POPDC1 1C12 localised to the 14 
sarcolemma of human skeletal muscle sections. This localisation was prevented by pre-15 
incubation of the mAb with recombinant POPDC1 but not when the mAb was pre-incubated 16 
with recombinant POPDC2. Also, (D) localisation of mAb POPDC2 12G12 to the sarcolemma 17 
was not inhibited by pre-incubation with recombinant POPDC1 but this localisation was 18 
inhibited when the mAb was pre-incubated with recombinant POPDC2. 19 
 20 
Figure 3 21 
Immunolocalisation of POPDC1/2, XIRP1 and annexin A5 at intercalated discs and myofibrils 22 
in rat heart. 23 
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In rat heart, intercalated discs were labelled with polyclonal antibody against connexin 43. 1 
(A) XIRP1 colocalised with connexin 43 at the intercalated disc and also stained myofibrils. 2 
(B) POPDC2 colocalises with XIRP1 at intercalated discs and myofibrils and POPDC2 is also 3 
present at the cardiac sarcolemma. (C) POPDC1 is similar to POPDC2, locating to 4 
intercalated discs and sarcolemma and to the centre of the actin I-band stained by 5 
phalloidin. (D) Annexin A5 colocalises with XIRP1. (E) POPDC2 colocalises with amphiphysin 6 
II, a marker for T-tubules. 7 
 8 
Figure 4 9 
Immunolocalisation of POPDC1, POPDC2 and XIRP1 in human heart. 10 
(A) POPDC1 and (B) POPDC2 were present at the sarcolemma and at intercalated discs. 11 
XIRP1 was also present at intercalated discs. Cross striations were difficult to resolve in the 12 
human heart sections. 13 
 14 
Figure 5 15 
Immunolocalisation of POPDC1/2, XIRP1 and annexin A5 at myofibrils in longitudinal 16 
sections of human skeletal muscle. 17 
(A) POPDC1 and XIRP1, (B) POPDC2 and XIRP1, (C) XIRP1 and Actinin, (D) Annexin A5 and 18 
XIRP1, all colocalised at myofibrils. 19 
 20 
Figure 6 21 
Immunolocalisation of POPDC1/2 and XIRP1 in transverse section of human skeletal muscle. 22 
(A) POPDC1 mAb 1C12 and (B) POPDC2 mAb 12G12 showed largely even and regular 23 
sarcolemmal staining whereas XIRP1 was often discontinuous at the sarcolemma. 24 
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 1 
 2 
Table 1: Mass spectrometry abridged results of mouse POPDC1/2 pull-downs 3 
 Accession 
number 
Number of significant 
(unique) peptides 
  mPOPDC1 mPOPDC2 
Actin, alpha cardiac muscle 1  ACTC_HUMAN 12 12 
Xin actin-binding repeat-containing 
protein 1  
XIRP1_HUMAN 11 19 
Tubulin beta-4B chain  TBB4B_HUMAN 9 7 
Tubulin beta chain  TBB5_HUMAN 9 6 
Tubulin beta-6 chain  TBB6_HUMAN 9 4 
ATP synthase subunit beta, 
mitochondrial  
ATPB_HUMAN 7 5 
Fructose-bisphosphate aldolase A  ALDOA_HUMAN 5 7 
L-lactate dehydrogenase A chain  LDHA_HUMAN 5 5 
Histone H2AX H2AX_HUMAN 4 4 
PDZ and LIM domain protein 3  PDLI3_HUMAN 3 5 
Glucosidase 2 subunit beta  GLU2B_HUMAN 3 5 
Lamina-associated polypeptide 2 
(beta/gamma) 
LAP2B_HUMAN 3 4 
Histone H2A.V  H2AV_HUMAN 3 4 
Phosphoglycerate mutase 1 PGAM1_HUMAN 3 4 
Phosphoglycerate kinase 1  PGK1_HUMAN 3 4 
Heat shock protein beta-2  HSPB2_HUMAN 3 4 
Annexin A5  ANXA5_HUMAN 3 3 
40S ribosomal protein S30  RS30_HUMAN 3 3 
 4 
Only proteins that met the following criteria are shown: identified from more than two 5 
significant unique peptide sequences, undetected in the control pull-down AND detected 6 
across both mPOPDC1 and mPOPDC2 pull-downs. See Additional file 1 for full results.  7 
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